Latest On Editas Medicine, Inc (EDIT):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 19:53 EST | News | Editas Medicine strengthens board of directors with appointment of new chair and new director | N/A |  |
| 2023-05-17 02:54 EST | News | Editas Medicine, Inc. (EDIT) RBC Capital Markets Global Healthcare Conference 2023 Transcript | N/A | |
| 2023-05-17 02:54 EST | News | Editas Medicine appoints Erick Lucera as CFO, Michelle Robertson steps down | N/A | |
| 2023-05-14 04:40 EST | News | Editas Medicine, Inc. (EDIT) Bank of America Global Healthcare Conference Call Transcript | N/A | |
| 2023-05-06 02:18 EST | News | Editas Medicine, Inc. (EDIT) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-06 02:18 EST | News | Editas Medicine: Pioneering Gene-Editing Solutions For Inherited Blood Disorders And Beyond | N/A | |
| 2023-05-05 13:29 EST | News | Editas Medicine GAAP EPS of -$0.71 beats by $0.08 | N/A | |
| 2023-05-05 00:35 EST | News | Editas Medicine Q1 2023 Earnings Preview | N/A | |
| 2023-04-27 18:11 EST | News | Editas sickle cell candidate granted FDA Orphan Drug designation | N/A | |
| 2023-04-13 20:11 EST | News | Hot Stocks: PGR drops on earnings; CNSL rises on buyout offer; MRK higher on analyst upgrade; EDIT gains; HOG slides | N/A | |
| 2023-04-13 20:11 EST | News | Gene editing stocks rally as Wall Street turns bullish | N/A | |
| 2023-02-24 03:35 EST | News | Editas: The Potential Of Gene Editing Technology And The Risks Of A Lackluster Pipeline | N/A | |
| 2023-02-23 01:21 EST | News | Editas rises on Q4 revenue beat, gene-editing therapy data for sickle cell disease by mid-year | N/A | |
| 2023-02-23 01:21 EST | News | Editas Medicine, Inc. (EDIT) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-22 12:28 EST | News | Editas Medicine GAAP EPS of -$0.88 misses by $0.08, revenue of $6.54M beats by $2.78M | N/A | |
| 2023-02-21 23:52 EST | News | Editas Medicine Q4 2022 Earnings Preview | N/A | |
| 2023-02-01 16:15 EST | News | Editas, Beam win bullish views as Cantor launches gene editing coverage | N/A | |
| 2023-01-19 18:17 EST | News | Editas to sell natural killer cell programs to Shoreline | N/A | |
| 2023-01-11 22:12 EST | News | Editas Medicine, Inc. (EDIT) Presents at 41st Annual J.P. Morgan Healthcare Conference (Transcript) | N/A | |
| 2023-01-09 15:48 EST | News | Editas cuts 20% staff in portfolio overhaul | N/A | |
| 2022-12-06 18:46 EST | News | Editas adds 12% after initial data for sickle cell disease candidate | N/A | |
| 2022-12-06 18:46 EST | News | Editas Medicine, Inc. (EDIT) EDIT-301 Clinical Update 2022 - (Transcript) | N/A | |
| 2022-12-06 18:45 EST | News | EDIT-301 Clinical Update | N/A | |
| 2022-12-06 18:45 EST | News | Editas Medicine: 3 Positives To Cling To In 2023 (And Why They May Not Be So Positive) | N/A | |
| 2022-11-18 13:41 EST | News | Editas Medicine dropped to neutral at Credit Suisse following EDIT-101 trial data | N/A | |
| 2022-11-17 20:34 EST | News | Editas pausing enrollment of blindness drug trial to find partner; shares down 15% | N/A | |
| 2022-11-04 19:09 EST | News | Editas Medicine: Q3 Update And 2 Clinical Catalysts To Watch | N/A | |
| 2022-11-02 16:42 EST | News | Editas Medicine GAAP EPS of -$0.81 beats by $0.07 | N/A | |
| 2022-11-02 16:41 EST | News | Editas Medicine, Inc. (EDIT) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-02 16:41 EST | News | Editas Medicine rises 7% on Q3 earnings beat | N/A | |
| 2022-11-02 01:05 EST | News | Editas Medicine Q3 2022 Earnings Preview | N/A | |
| 2022-10-18 18:19 EST | News | Editas Medicine gains on report of potential sale of pre-clinical cancer pipeline | N/A | |
| 2022-09-30 01:23 EST | News | Editas Medicine started at neutral at BofA due to competition in gene editing programs | N/A | |
| 2022-09-12 17:06 EST | News | Editas Medicine, Inc. (EDIT) Management Presents at Morgan Stanley 20th Annual Global Healthcare Conference Call Transcript | N/A | |
| 2022-09-08 10:35 EST | News | Editas Medicine, Inc. (EDIT) Presents at 2022 Wells Fargo Healthcare Conference (Transcript) | N/A | |
| 2022-08-25 11:55 EST | News | Editas Medicine: Management Upbeat After Lifting Of Clinical Hold | N/A | |
| 2022-08-24 03:30 EST | News | Editas: End Of Year Data Readouts For SCD And Rare Eye Disease Studies | N/A | |
| 2022-08-04 10:30 EST | News | Editas Medicine, Inc. (EDIT) CEO Gilmore O'Neill on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-03 20:10 EST | News | Editas Medicine GAAP EPS of -$0.78 beats by $0.06, revenue of $6.36M beats by $2.07M | N/A | |
| 2022-08-03 20:10 EST | News | Editas Medicine up 13% following Q2 2022 top and bottom line beats as net loss narrows | N/A | |
| 2022-08-03 20:09 EST | News | Gene editing companies benefitting from Roche deal with CAR-T player Poseida Therapeutics | N/A | |
| 2022-08-02 14:41 EST | News | Editas Medicine Q2 2022 Earnings Preview | N/A | |
| 2022-07-18 11:17 EST | News | Baisong Mei joins Editas Medicine as Chief Medical Officer | N/A | |
| 2022-06-07 11:20 EST | News | Editas in licensing deal with Immatics for cancer therapies | N/A | |
| 2022-06-06 20:01 EST | News | Editas: Tackling Rare Eye Disease With Use Of Crispr Technology | N/A | |
| 2022-05-13 12:13 EST | News | Editas Medicine granted Orphan Drug Designation for beta thalassemia candidate | N/A | |
| 2022-05-05 02:50 EST | News | Editas Medicine GAAP EPS of -$0.74 beats by $0.07, revenue of $6.77M beats by $2.92M | N/A | |
| 2022-05-05 02:50 EST | News | Editas Medicine, Inc. (EDIT) CEO Jim Mullen on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-04 06:05 EST | News | Editas Medicine Q1 2022 Earnings Preview | N/A | |
| 2022-04-26 11:41 EST | News | Editas gets FDA rare pediatric disease status for gene-edited drug EDIT-301 for beta thalassemia | N/A | |
About Editas Medicine, Inc (EDIT):
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary genome editing platform based on CRISPR technology to target genetically addressable diseases and therapeutic areas. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis type 10, a genetic form of vision loss that leads to blindness in childhood. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa 4, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumors; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has a early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio and collaboration with m BlueRock Therapeutics LP. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.
General
- Name Editas Medicine, Inc
- Symbol EDIT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 235
- Fiscal Year EndDecember
- IPO Date2016-02-03
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.editasmedicine.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 26.85
- Price/Book (Most Recent Quarter) 6.25
- Enterprise Value Revenue 25.23
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.34
- Next Year EPS Estimate -$3.49
- Next Quarter EPS Estimate -$0.78
- Profit Margin -128%
- Operating Margin -149%
- Return on Assets -16%
- Return on Equity -35%
- Revenue 90.73 million
- Earnings Per Share -$2.14
- Revenue Per Share $1.55
- Gross Profit -67264000
- Quarterly Earnings Growth -7%
View More
Highlights
- Market Capitalization 2.91 billion
- EBITDA -106383000
- PE Ratio -1.59
- Analyst Target Price $52.83
- Book Value Per Share $6.29
View More
Share Statistics
- Shares Outstanding 67.36 million
- Shares Float 66.37 million
- % Held by Insiders 137%
- % Held by Institutions 82.21%
- Shares Short 11.31 million
- Shares Short Prior Month 9.84 million
- Short Ratio 4.22
- Short % of Float 17%
- Short % of Shares Outstanding 17%
View More
Technicals
- Beta 2.08
- 52 Week High $99.95
- 52 Week Low $18.2
- 50 Day Moving Average 52.94
- 200 Day Moving Average 46.49
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Editas Medicine, Inc (EDIT) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Editas Medicine, Inc (EDIT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$1.00 | -$0.88 | -13.56% |
| 2020-09-30 | 2020-11-05 | $N/A | $0.12 | -$0.63 | 119.14% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.43 | -$0.82 | 47.37% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.69 | -$0.81 | 14.81% |
| 2019-12-31 | 2020-02-26 | $12.28 million | -$0.74 | $0.06 | -1380.28% |
| 2019-09-30 | 2019-11-12 | $3.85 million | -$0.66 | -$0.73 | 9.3% |
| 2019-06-30 | 2019-08-06 | $2.33 million | -$0.69 | -$0.62 | -10.79% |
| 2019-03-31 | 2019-05-07 | $2.07 million | -$0.60 | -$0.64 | 5.78% |
| 2018-12-31 | 2019-02-28 | $6.12 million | -$0.52 | -$0.55 | 5.45% |
| 2018-09-30 | 2018-11-07 | $14.52 million | -$0.32 | -$0.81 | 60.7% |
| 2018-06-30 | 2018-08-06 | $7.37 million | -$0.82 | -$0.66 | -25.1% |
| 2018-03-31 | 2018-05-03 | $3.93 million | -$0.67 | -$0.80 | 16.47% |
| 2017-12-31 | 2018-03-06 | $3.67 million | -$0.84 | -$0.67 | -25.88% |
| 2017-09-30 | 2017-11-07 | $6.28 million | -$0.64 | -$0.63 | -1.81% |
| 2017-06-30 | 2017-08-09 | $3.1 million | -$0.65 | -$0.57 | -13.38% |
| 2017-03-31 | 2017-05-15 | $682000 | -$0.85 | -$0.77 | -11.05% |
| 2016-12-31 | 2017-03-03 | $898000 | -$1.10 | -$0.65 | -68.69% |
| 2016-09-30 | 2016-11-07 | $962000 | -$0.59 | -$0.64 | 8% |
| 2016-06-30 | 2016-08-09 | $3.39 million | -$0.54 | -$0.56 | 2.76% |
| 2016-03-31 | 2016-05-13 | $805000 | -$0.80 | -$0.32 | -150.94% |
| 2015-12-31 | 2016-03-30 | $792000 | -$4.05 | -$8.56 | 52.69% |
Editas Medicine, Inc (EDIT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Editas Medicine, Inc (EDIT) Chart:
Editas Medicine, Inc (EDIT) News:
Below you will find a list of latest news for Editas Medicine, Inc (EDIT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Editas Medicine, Inc (EDIT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 | 0.5 | 1.06 | CALL | 10 | 52 | 0 | TRUE | -0.1 | -0.09 |
| 2025-05-16 | 1 | 0.58 | CALL | 42 | 476 | 0 | TRUE | 0 | 0 |
| 2025-05-16 | 1.5 | 0.29 | CALL | 80 | 1345 | 151.19 | TRUE | 0.05 | 0.21 |
| 2025-05-16 | 2 | 0.05 | CALL | 9 | 1512 | 103.15 | FALSE | 0 | 0 |
| 2025-05-16 | 2.5 | 0.03 | CALL | 69 | 4520 | 136.58 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0.04 | CALL | 0 | 2101 | 256.81 | FALSE | 0 | 0 |
| 2025-05-16 | 7.5 | 0.05 | CALL | 0 | 937 | 320.89 | FALSE | 0 | 0 |
| 2025-05-16 | 0.5 | 0.05 | PUT | 0 | 151 | 338.04 | FALSE | 0 | 0 |
| 2025-05-16 | 1 | 0.06 | PUT | 0 | 86 | 157.31 | FALSE | 0 | 0 |
| 2025-05-16 | 1.5 | 0.19 | PUT | 10 | 588 | 160.52 | FALSE | 0.02 | 0.12 |
| 2025-05-16 | 2 | 0.53 | PUT | 5 | 100 | 170.84 | TRUE | 0.53 | 0 |
| 2025-05-16 | 2.5 | 1.1 | PUT | 0 | 441 | 212.72 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 3.02 | PUT | 0 | 5 | 513.46 | TRUE | 0 | 0 |
| 2025-05-16 | 7.5 | 4.7 | PUT | 0 | 0 | 525.86 | TRUE | 0 | 0 |
| 2025-06-20 | 0.5 | 1.1 | CALL | 0 | 88 | 0 | TRUE | 0 | 0 |
| 2025-06-20 | 1 | 0.96 | CALL | 10 | 12 | 318.95 | TRUE | 0.24 | 0.33 |
| 2025-06-20 | 1.5 | 0.3 | CALL | 0 | 1 | 96.85 | TRUE | 0 | 0 |
| 2025-06-20 | 2 | 0.05 | CALL | 0 | 1 | 86.56 | FALSE | 0 | 0 |
| 2025-06-20 | 2.5 | 0.1 | CALL | 0 | 5 | 135.97 | FALSE | 0 | 0 |
| 2025-06-20 | 5 | 0 | CALL | 0 | 0 | 647.74 | FALSE | 0 | 0 |
| 2025-06-20 | 7.5 | 0 | CALL | 0 | 0 | 338.17 | FALSE | 0 | 0 |
| 2025-06-20 | 0.5 | 0 | PUT | 0 | 0 | 210.65 | FALSE | 0 | 0 |
| 2025-06-20 | 1 | 0 | PUT | 0 | 0 | 122.15 | FALSE | 0 | 0 |
| 2025-06-20 | 1.5 | 0 | PUT | 0 | 0 | 83.86 | FALSE | 0 | 0 |
| 2025-06-20 | 2 | 0 | PUT | 0 | 0 | 156.18 | TRUE | 0 | 0 |
| 2025-06-20 | 2.5 | 0 | PUT | 0 | 0 | 257.65 | TRUE | 0 | 0 |
| 2025-06-20 | 5 | 0 | PUT | 0 | 0 | 485.16 | TRUE | 0 | 0 |
| 2025-06-20 | 7.5 | 0 | PUT | 0 | 0 | 538.61 | TRUE | 0 | 0 |
| 2025-08-15 | 0.5 | 1.7 | CALL | 90 | 119 | 0 | TRUE | 0.3 | 0.21 |
| 2025-08-15 | 1 | 0.76 | CALL | 20 | 505 | 132.92 | TRUE | -0.34 | -0.31 |
| 2025-08-15 | 1.5 | 0.45 | CALL | 1 | 588 | 113.15 | TRUE | 0.05 | 0.13 |
| 2025-08-15 | 2 | 0.25 | CALL | 50 | 597 | 103.89 | FALSE | 0 | 0 |
| 2025-08-15 | 2.5 | 0.17 | CALL | 70 | 755 | 109.83 | FALSE | -0.01 | -0.06 |
| 2025-08-15 | 5 | 0.05 | CALL | 0 | 570 | 153.29 | FALSE | 0 | 0 |
| 2025-08-15 | 7.5 | 0.1 | CALL | 0 | 321 | 173.72 | FALSE | 0 | 0 |
| 2025-08-15 | 0.5 | 0 | PUT | 0 | 0 | 373.74 | FALSE | 0 | 0 |
| 2025-08-15 | 1 | 0.14 | PUT | 0 | 106 | 101.79 | FALSE | 0 | 0 |
| 2025-08-15 | 1.5 | 0.65 | PUT | 0 | 39 | 75.96 | FALSE | 0 | 0 |
| 2025-08-15 | 2 | 0.85 | PUT | 0 | 136 | 120.08 | TRUE | 0 | 0 |
| 2025-08-15 | 2.5 | 1.3 | PUT | 0 | 158 | 99.12 | TRUE | 0 | 0 |
| 2025-08-15 | 5 | 3.08 | PUT | 0 | 110 | 292.58 | TRUE | 0 | 0 |
| 2025-08-15 | 7.5 | 0 | PUT | 0 | 0 | 722.91 | TRUE | 0 | 0 |
| 2025-11-21 | 0.5 | 1.3 | CALL | 110 | 35 | 225.24 | TRUE | -0.2 | -0.13 |
| 2025-11-21 | 1 | 1.16 | CALL | 175 | 408 | 237.89 | TRUE | 0.36 | 0.45 |
| 2025-11-21 | 1.5 | 0.57 | CALL | 0 | 53 | 230.3 | TRUE | 0 | 0 |
| 2025-11-21 | 2 | 0.5 | CALL | 0 | 54 | 95.37 | FALSE | 0 | 0 |
| 2025-11-21 | 2.5 | 0.25 | CALL | 0 | 50 | 96.53 | FALSE | 0 | 0 |
| 2025-11-21 | 5 | 0.1 | CALL | 0 | 79 | 125.42 | FALSE | 0 | 0 |
| 2025-11-21 | 7.5 | 0.05 | CALL | 0 | 1 | 168.9 | FALSE | 0 | 0 |
| 2025-11-21 | 0.5 | 0 | PUT | 0 | 0 | 275.8 | FALSE | 0 | 0 |
| 2025-11-21 | 1 | 0.2 | PUT | 0 | 1 | 85.15 | FALSE | 0 | 0 |
| 2025-11-21 | 1.5 | 0 | PUT | 0 | 0 | 91.02 | FALSE | 0 | 0 |
| 2025-11-21 | 2 | 0.7 | PUT | 0 | 7 | 59.22 | TRUE | 0 | 0 |
| 2025-11-21 | 2.5 | 0 | PUT | 0 | 0 | 103.21 | TRUE | 0 | 0 |
| 2025-11-21 | 5 | 3.5 | PUT | 0 | 0 | 371.11 | TRUE | 0 | 0 |
| 2025-11-21 | 7.5 | 0 | PUT | 0 | 0 | 295.94 | TRUE | 0 | 0 |
| 2026-01-16 | 0.5 | 1.23 | CALL | 130 | 126 | 156.81 | TRUE | 1.23 | 0 |
| 2026-01-16 | 1 | 0.8 | CALL | 170 | 2164 | 95.69 | TRUE | -0.06 | -0.07 |
| 2026-01-16 | 1.5 | 0.63 | CALL | 15 | 1376 | 108.86 | TRUE | 0.03 | 0.05 |
| 2026-01-16 | 2 | 0.4 | CALL | 1 | 1225 | 93.35 | FALSE | -0.04 | -0.09 |
| 2026-01-16 | 2.5 | 0.32 | CALL | 1 | 4728 | 98.16 | FALSE | -0.08 | -0.2 |
| 2026-01-16 | 5 | 0.17 | CALL | 3 | 5267 | 115.63 | FALSE | 0.17 | 0 |
| 2026-01-16 | 7.5 | 0.1 | CALL | 0 | 1599 | 126.71 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 0.11 | CALL | 0 | 2324 | 133.7 | FALSE | 0 | 0 |
| 2026-01-16 | 12.5 | 0.05 | CALL | 0 | 776 | 135.68 | FALSE | 0 | 0 |
| 2026-01-16 | 15 | 0.05 | CALL | 0 | 721 | 143.58 | FALSE | 0 | 0 |
| 2026-01-16 | 17.5 | 0.05 | CALL | 0 | 416 | 139.76 | FALSE | 0 | 0 |
| 2026-01-16 | 20 | 0.2 | CALL | 0 | 1121 | 164.27 | FALSE | 0 | 0 |
| 2026-01-16 | 0.5 | 0.05 | PUT | 0 | 4 | 229.93 | FALSE | 0 | 0 |
| 2026-01-16 | 1 | 0.19 | PUT | 0 | 169 | 84.41 | FALSE | 0 | 0 |
| 2026-01-16 | 1.5 | 0.45 | PUT | 0 | 383 | 66.6 | FALSE | 0 | 0 |
| 2026-01-16 | 2 | 0.79 | PUT | 0 | 180 | 39.01 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 1.22 | PUT | 0 | 353 | 79.14 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 4 | PUT | 0 | 175 | 142.84 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 5.78 | PUT | 0 | 99 | 161.33 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 8.7 | PUT | 0 | 9 | 169.93 | TRUE | 0 | 0 |
| 2026-01-16 | 12.5 | 8.83 | PUT | 0 | 0 | 185.68 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 6.8 | PUT | 0 | 0 | 198.85 | TRUE | 0 | 0 |
| 2026-01-16 | 17.5 | 8.6 | PUT | 0 | 0 | 210.32 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 18.64 | PUT | 0 | 0 | 283.69 | TRUE | 0 | 0 |
Latest EDIT Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 6 | $9.99 |
| Jun 13, 2022 7:59 PM EST | 1 | $9.99 |
| Jun 13, 2022 7:59 PM EST | 1 | $9.99 |
| Jun 13, 2022 7:59 PM EST | 4 | $9.99 |
| Jun 13, 2022 7:59 PM EST | 7 | $9.99 |
Editas Medicine, Inc (EDIT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000110465920076658/0001104659-20-076658-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000009375119000066/0000093751-19-000066-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000021545719004070/0000215457-19-004070-index.htm |
| 2018-08-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000031506618002155/0000315066-18-002155-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000083423720005329/0000834237-20-005329-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000093247119004821/0000932471-19-004821-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000093247119004830/0000932471-19-004830-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000095010320002668/0000950103-20-002668-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1650664/000104746919002633/0001047469-19-002633-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1650664/000104746920002641/0001047469-20-002641-index.htm |
| 2020-05-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1650664/000104746920003096/0001047469-20-003096-index.htm |
| 2020-06-23 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1650664/000104746920003806/0001047469-20-003806-index.htm |
| 2020-06-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1650664/000104746920003852/0001047469-20-003852-index.htm |
| 2019-01-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm |
| 2019-04-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1650664/000110465919024075/0001104659-19-024075-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000110465920018014/0001104659-20-018014-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000110465920021157/0001104659-20-021157-index.htm |
| 2020-04-28 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1650664/000110465920052376/0001104659-20-052376-index.htm |
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000110465920076658/0001104659-20-076658-index.htm |
| 2020-10-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000110465920113794/0001104659-20-113794-index.htm |
| 2019-10-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000114036119018224/0001140361-19-018224-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000114036120002957/0001140361-20-002957-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000114420419007778/0001144204-19-007778-index.htm |
| 2018-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm |
| 2018-07-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm |
| 2018-07-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2018-08-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm |
| 2018-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm |
| 2018-08-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm |
| 2018-09-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm |
| 2018-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm |
| 2018-10-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm |
| 2018-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm |
| 2018-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm |
| 2018-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm |
| 2018-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm |
| 2018-12-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013607/0001179110-18-013607-index.htm |
| 2018-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013609/0001179110-18-013609-index.htm |
| 2018-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm |
| 2019-01-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019000574/0001179110-19-000574-index.htm |
| 2019-01-08 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019000576/0001179110-19-000576-index.htm |
| 2019-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019000653/0001179110-19-000653-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001235/0001179110-19-001235-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001237/0001179110-19-001237-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001239/0001179110-19-001239-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm |
| 2019-02-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001511/0001179110-19-001511-index.htm |
| 2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001519/0001179110-19-001519-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001682/0001179110-19-001682-index.htm |
| 2019-02-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001684/0001179110-19-001684-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm |
| 2019-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019003510/0001179110-19-003510-index.htm |
| 2019-03-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019003602/0001179110-19-003602-index.htm |
| 2019-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019007669/0001179110-19-007669-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019007675/0001179110-19-007675-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019007680/0001179110-19-007680-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019007682/0001179110-19-007682-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019007685/0001179110-19-007685-index.htm |
| 2019-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019009249/0001179110-19-009249-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm |
| 2019-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019010316/0001179110-19-010316-index.htm |
| 2019-10-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019011287/0001179110-19-011287-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911019011289/0001179110-19-011289-index.htm |
| 2020-01-10 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020000466/0001179110-20-000466-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020000468/0001179110-20-000468-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001362/0001179110-20-001362-index.htm |
| 2020-02-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm |
| 2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020005605/0001179110-20-005605-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020007263/0001179110-20-007263-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020007265/0001179110-20-007265-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020007273/0001179110-20-007273-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020007277/0001179110-20-007277-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020007280/0001179110-20-007280-index.htm |
| 2020-07-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020008367/0001179110-20-008367-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm |
| 2020-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020009219/0001179110-20-009219-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000117911020010507/0001179110-20-010507-index.htm |
| 2018-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm |
| 2019-10-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1650664/000121465919006312/0001214659-19-006312-index.htm |
| 2018-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837018006448/0001558370-18-006448-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837018006577/0001558370-18-006577-index.htm |
| 2018-10-23 | 10-Q/A | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837018007793/0001558370-18-007793-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837018008795/0001558370-18-008795-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837018008907/0001558370-18-008907-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837018009647/0001558370-18-009647-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837018009781/0001558370-18-009781-index.htm |
| 2019-01-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019000186/0001558370-19-000186-index.htm |
| 2019-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019000455/0001558370-19-000455-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019001317/0001558370-19-001317-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1650664/000155837019001364/0001558370-19-001364-index.htm |
| 2019-03-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1650664/000155837019002001/0001558370-19-002001-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019004256/0001558370-19-004256-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837019004444/0001558370-19-004444-index.htm |
| 2019-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019005722/0001558370-19-005722-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019007255/0001558370-19-007255-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837019007470/0001558370-19-007470-index.htm |
| 2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019008737/0001558370-19-008737-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837019010674/0001558370-19-010674-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837019010798/0001558370-19-010798-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020000118/0001558370-20-000118-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020001469/0001558370-20-001469-index.htm |
| 2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1650664/000155837020001476/0001558370-20-001476-index.htm |
| 2020-02-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1650664/000155837020001479/0001558370-20-001479-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020005306/0001558370-20-005306-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020005548/0001558370-20-005548-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837020005883/0001558370-20-005883-index.htm |
| 2020-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020006724/0001558370-20-006724-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020007536/0001558370-20-007536-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020009648/0001558370-20-009648-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837020009821/0001558370-20-009821-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1650664/000155837020012865/0001558370-20-012865-index.htm |
| 2020-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1650664/000155837020013022/0001558370-20-013022-index.htm |
| 2018-10-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1650664/999999999718008672/9999999997-18-008672-index.htm |
| 2018-10-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1650664/999999999718008675/9999999997-18-008675-index.htm |
| 2018-10-18 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1650664/999999999718008677/9999999997-18-008677-index.htm |
| 2018-10-25 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1650664/999999999718008797/9999999997-18-008797-index.htm |
| 2019-09-23 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1650664/999999999719007052/9999999997-19-007052-index.htm |
| 2019-09-26 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1650664/999999999719007131/9999999997-19-007131-index.htm |
| 2019-10-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1650664/999999999719007341/9999999997-19-007341-index.htm |
| 2019-12-26 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1650664/999999999719007956/9999999997-19-007956-index.htm |
| 2020-04-27 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1650664/999999999720002192/9999999997-20-002192-index.htm |
Editas Medicine, Inc (EDIT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Editas Medicine, Inc (EDIT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 137%Institutional Ownership: 8221%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-08-31 | Andrew A. F. Hack | Chief Financial Officer | Sell | 10,000.00 | 32.23 | 322,300.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm |
| 2018-09-28 | Andrew A. F. Hack | Chief Financial Officer | Sell | 8,000.00 | 32.08 | 256,640.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm |
| 2018-10-26 | Andrew A. F. Hack | Chief Financial Officer | Sell | 6,000.00 | 25.70 | 154,200.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm |
| 2018-11-23 | Andrew A. F. Hack | Chief Financial Officer | Sell | 100.00 | 28.61 | 2,861.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm |
| 2019-01-04 | Andrew A. F. Hack | Chief Financial Officer | Sell | 7,000.00 | 22.48 | 157,360.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm |
| 2019-02-04 | Andrew A. F. Hack | Chief Financial Officer | Sell | 6,895.00 | 21.39 | 147,484.05 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm |
| 2018-06-18 | Vickesh Myer | Chief Technology Officer | Sell | 4,300.00 | 37.75 | 162,325.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm |
| 2018-06-18 | Vickesh Myer | Chief Technology Officer | Sell | 2,700.00 | 38.71 | 104,517.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm |
| 2018-06-19 | Vickesh Myer | Chief Technology Officer | Sell | 7,000.00 | 38.39 | 268,730.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm |
| 2018-07-17 | Vickesh Myer | Chief Technology Officer | Sell | 3,000.00 | 34.66 | 103,980.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2018-07-17 | Vickesh Myer | Chief Technology Officer | Sell | 4,000.00 | 36.50 | 146,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2018-07-18 | Vickesh Myer | Chief Technology Officer | Sell | 6,150.00 | 35.46 | 218,079.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2018-07-18 | Vickesh Myer | Chief Technology Officer | Sell | 850.00 | 36.25 | 30,812.50 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2018-08-17 | Vickesh Myer | Chief Technology Officer | Sell | 3,000.00 | 29.65 | 88,950.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm |
| 2018-08-20 | Vickesh Myer | Chief Technology Officer | Sell | 3,600.00 | 29.81 | 107,316.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm |
| 2018-08-20 | Vickesh Myer | Chief Technology Officer | Sell | 400.00 | 30.41 | 12,164.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm |
| 2018-09-17 | Vickesh Myer | Chief Technology Officer | Sell | 3,000.00 | 32.33 | 96,990.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm |
| 2018-09-18 | Vickesh Myer | Chief Technology Officer | Sell | 4,000.00 | 32.19 | 128,760.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm |
| 2018-10-17 | Vickesh Myer | Chief Technology Officer | Sell | 3,000.00 | 28.87 | 86,610.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm |
| 2018-10-18 | Vickesh Myer | Chief Technology Officer | Sell | 4,000.00 | 29.44 | 117,760.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm |
| 2018-11-19 | Vickesh Myer | Chief Technology Officer | Sell | 2,700.00 | 28.12 | 75,924.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm |
| 2018-11-19 | Vickesh Myer | Chief Technology Officer | Sell | 300.00 | 28.85 | 8,655.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm |
| 2018-11-20 | Vickesh Myer | Chief Technology Officer | Sell | 4,000.00 | 26.50 | 106,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm |
| 2018-12-17 | Vickesh Myer | Chief Technology Officer | Sell | 700.00 | 28.34 | 19,838.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm |
| 2018-12-18 | Vickesh Myer | Chief Technology Officer | Sell | 4,000.00 | 27.41 | 109,640.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm |
| 2019-01-17 | Vickesh Myer | Chief Technology Officer | Sell | 3,000.00 | 26.18 | 78,540.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm |
| 2019-01-18 | Vickesh Myer | Chief Technology Officer | Sell | 4,000.00 | 26.50 | 106,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm |
| 2019-02-20 | Vickesh Myer | Chief Technology Officer | Sell | 3,000.00 | 20.42 | 61,260.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm |
| 2019-03-18 | Vickesh Myer | Chief Technology Officer | Sell | 3,000.00 | 24.50 | 73,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm |
| 2018-11-23 | Andrew A. F. Hack | Chief Financial Officer | Sell | 5,184.00 | 28.14 | 145,877.76 | 100.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm |
| 2018-08-31 | Andrew A. F. Hack | Chief Financial Officer | Buy | 10,000.00 | 6.48 | 64,800.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000118248918000336/0001182489-18-000336-index.htm |
| 2019-08-19 | Cynthia Collins | CEO | Sell | 5,193.00 | 25.83 | 134,135.19 | 11,373.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm |
| 2019-01-08 | Katrine Bosley | President and CEO | Sell | 12,000.00 | 25.27 | 303,240.00 | 1,204,966.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019000653/0001179110-19-000653-index.htm |
| 2018-12-03 | Katrine Bosley | President and CEO | Sell | 100.00 | 32.39 | 3,239.00 | 1,216,966.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm |
| 2018-12-03 | Katrine Bosley | President and CEO | Sell | 11,900.00 | 31.92 | 379,848.00 | 1,217,066.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013511/0001179110-18-013511-index.htm |
| 2018-11-01 | Katrine Bosley | President and CEO | Sell | 8,600.00 | 27.21 | 234,006.00 | 1,228,966.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm |
| 2018-11-01 | Katrine Bosley | President and CEO | Sell | 3,400.00 | 26.03 | 88,502.00 | 1,237,566.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012584/0001179110-18-012584-index.htm |
| 2018-10-01 | Katrine Bosley | President and CEO | Sell | 5,766.00 | 31.44 | 181,283.04 | 1,240,966.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm |
| 2018-10-01 | Katrine Bosley | President and CEO | Sell | 6,234.00 | 30.64 | 191,009.76 | 1,246,732.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011999/0001179110-18-011999-index.htm |
| 2018-09-04 | Katrine Bosley | President and CEO | Sell | 1,213.00 | 33.07 | 40,113.91 | 1,252,966.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm |
| 2018-09-04 | Katrine Bosley | President and CEO | Sell | 10,787.00 | 32.27 | 348,096.49 | 1,254,179.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011143/0001179110-18-011143-index.htm |
| 2018-08-20 | Katrine Bosley | President and CEO | Sell | 5,433.00 | 30.43 | 165,326.19 | 1,264,966.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm |
| 2018-08-20 | Katrine Bosley | President and CEO | Sell | 6,567.00 | 29.95 | 196,681.65 | 1,270,399.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010766/0001179110-18-010766-index.htm |
| 2018-08-01 | Katrine Bosley | President and CEO | Sell | 2,100.00 | 30.12 | 63,252.00 | 1,276,966.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm |
| 2018-08-01 | Katrine Bosley | President and CEO | Sell | 6,233.00 | 29.36 | 183,000.88 | 1,279,066.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010246/0001179110-18-010246-index.htm |
| 2018-07-02 | Katrine Bosley | President and CEO | Sell | 5,333.00 | 36.46 | 194,441.18 | 1,285,299.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm |
| 2018-07-02 | Katrine Bosley | President and CEO | Sell | 3,000.00 | 36.00 | 108,000.00 | 1,290,632.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009472/0001179110-18-009472-index.htm |
| 2019-08-06 | Cynthia Collins | CEO | Buy | 8,283.00 | 16,566.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019009249/0001179110-19-009249-index.htm | ||
| 2019-08-19 | Cynthia Collins | CEO | Buy | 8,283.00 | 16,566.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019009744/0001179110-19-009744-index.htm | ||
| 2019-03-05 | Jessica Hopfield | Director | Buy | 10,200.00 | 23.94 | 244,188.00 | 16,900.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019003510/0001179110-19-003510-index.htm |
| 2020-01-09 | MICHELLE ROBERTSON | Chief Financial Officer | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020000468/0001179110-20-000468-index.htm | ||
| 2020-02-03 | Charles Albright | Chief Scientific Officer | Sell | 5,549.00 | 26.54 | 147,287.66 | 20,553.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm |
| 2019-10-28 | Judith R Abrams | Chief Medical Officer | Buy | 25,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019011289/0001179110-19-011289-index.htm | ||
| 2020-10-15 | Charles Albright | EVP/Chief Scientific Officer | Sell | 3,000.00 | 31.39 | 94,170.00 | 25,135.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020010507/0001179110-20-010507-index.htm |
| 2020-01-31 | Charles Albright | Chief Scientific Officer | Buy | 17,977.00 | 26,102.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001026/0001179110-20-001026-index.htm | ||
| 2018-06-18 | Vickesh Myer | Chief Technology Officer | Buy | 2,700.00 | 0.65 | 1,755.00 | 2,700.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm |
| 2018-11-19 | Vickesh Myer | Chief Technology Officer | Buy | 2,700.00 | 0.65 | 1,755.00 | 2,700.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm |
| 2020-08-07 | Charles Albright | EVP/Chief Scientific Officer | Sell | 238.00 | 34.99 | 8,327.62 | 28,135.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm |
| 2020-08-17 | Charles Albright | EVP/Chief Scientific Officer | Sell | 10,000.00 | 35.29 | 352,900.00 | 28,135.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm |
| 2020-07-15 | Charles Albright | EVP/Chief Scientific Officer | Sell | 3,000.00 | 32.22 | 96,660.00 | 28,373.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020008367/0001179110-20-008367-index.htm |
| 2020-08-06 | Charles Albright | EVP/Chief Scientific Officer | Sell | 10,000.00 | 37.47 | 374,700.00 | 28,373.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm |
| 2018-11-19 | Vickesh Myer | Chief Technology Officer | Buy | 300.00 | 0.65 | 195.00 | 300.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm |
| 2018-07-17 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2018-08-17 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm |
| 2018-09-17 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm |
| 2018-10-17 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm |
| 2018-12-17 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm |
| 2019-01-17 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm |
| 2019-02-20 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019002313/0001179110-19-002313-index.htm |
| 2019-03-18 | Vickesh Myer | Chief Technology Officer | Buy | 3,000.00 | 0.65 | 1,950.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019004095/0001179110-19-004095-index.htm |
| 2020-05-06 | Charles Albright | EVP/Chief Scientific Officer | Sell | 151.00 | 25.28 | 3,817.28 | 31,373.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020005605/0001179110-20-005605-index.htm |
| 2019-09-11 | Cynthia Collins | CEO | Buy | 20,000.00 | 31,373.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019010316/0001179110-19-010316-index.htm | ||
| 2020-02-07 | Charles Albright | Chief Scientific Officer | Sell | 622.00 | 26.95 | 16,762.90 | 31,524.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm |
| 2020-02-06 | Charles Albright | Chief Scientific Officer | Buy | 11,593.00 | 32,146.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001370/0001179110-20-001370-index.htm | ||
| 2018-08-20 | Vickesh Myer | Chief Technology Officer | Buy | 3,600.00 | 11.21 | 40,356.00 | 3,600.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm |
| 2020-08-17 | Charles Albright | EVP/Chief Scientific Officer | Buy | 10,000.00 | 16.51 | 165,100.00 | 38,135.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020009170/0001179110-20-009170-index.htm |
| 2020-08-06 | Charles Albright | EVP/Chief Scientific Officer | Buy | 10,000.00 | 16.51 | 165,100.00 | 38,373.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020008833/0001179110-20-008833-index.htm |
| 2018-08-20 | Vickesh Myer | Chief Technology Officer | Buy | 400.00 | 11.21 | 4,484.00 | 400.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018010732/0001179110-18-010732-index.htm |
| 2018-07-17 | Vickesh Myer | Chief Technology Officer | Buy | 4,000.00 | 0.65 | 2,600.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2018-09-18 | Vickesh Myer | Chief Technology Officer | Buy | 4,000.00 | 11.21 | 44,840.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011549/0001179110-18-011549-index.htm |
| 2018-10-18 | Vickesh Myer | Chief Technology Officer | Buy | 4,000.00 | 11.21 | 44,840.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012272/0001179110-18-012272-index.htm |
| 2018-11-20 | Vickesh Myer | Chief Technology Officer | Buy | 4,000.00 | 11.21 | 44,840.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013070/0001179110-18-013070-index.htm |
| 2018-12-18 | Vickesh Myer | Chief Technology Officer | Buy | 4,000.00 | 11.21 | 44,840.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm |
| 2019-01-18 | Vickesh Myer | Chief Technology Officer | Buy | 4,000.00 | 11.21 | 44,840.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000110465919002543/0001104659-19-002543-index.htm |
| 2018-06-18 | Vickesh Myer | Chief Technology Officer | Buy | 4,300.00 | 0.65 | 2,795.00 | 4,300.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm |
| 2020-08-20 | Cynthia Collins | CEO | Sell | 1,976.00 | 36.66 | 72,440.16 | 45,022.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020009219/0001179110-20-009219-index.htm |
| 2020-02-06 | Cynthia Collins | CEO | Buy | 15,625.00 | 46,998.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911020001362/0001179110-20-001362-index.htm | ||
| 2018-11-23 | Andrew A. F. Hack | Chief Financial Officer | Buy | 5,284.00 | 6.48 | 34,240.32 | 5,284.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018013245/0001179110-18-013245-index.htm |
| 2018-10-26 | Andrew A. F. Hack | Chief Financial Officer | Buy | 6,000.00 | 6.48 | 38,880.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018012390/0001179110-18-012390-index.htm |
| 2018-07-18 | Vickesh Myer | Chief Technology Officer | Buy | 6,150.00 | 11.21 | 68,941.50 | 6,150.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |
| 2019-02-04 | Andrew A. F. Hack | Chief Financial Officer | Buy | 6,895.00 | 6.48 | 44,679.60 | 6,895.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019001436/0001179110-19-001436-index.htm |
| 2018-12-17 | Vickesh Myer | Chief Technology Officer | Sell | 2,300.00 | 27.75 | 63,825.00 | 700.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018014142/0001179110-18-014142-index.htm |
| 2019-01-04 | Andrew A. F. Hack | Chief Financial Officer | Buy | 7,000.00 | 6.48 | 45,360.00 | 7,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911019000578/0001179110-19-000578-index.htm |
| 2018-06-19 | Vickesh Myer | Chief Technology Officer | Buy | 7,000.00 | 11.21 | 78,470.00 | 7,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018008837/0001179110-18-008837-index.htm |
| 2018-09-28 | Andrew A. F. Hack | Chief Financial Officer | Buy | 8,000.00 | 6.48 | 51,840.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018011848/0001179110-18-011848-index.htm |
| 2018-07-18 | Vickesh Myer | Chief Technology Officer | Buy | 850.00 | 11.21 | 9,528.50 | 850.00 | https://www.sec.gov/Archives/edgar/data/1650664/000117911018009834/0001179110-18-009834-index.htm |